This randomized clinical trial assesses the safety and efficacy of carbon dioxide (CO2) vs sham vaginal laser treatment after 6 months of follow-up in survivors of breast cancer receiving aromatase inhibitors with genitourinary syndrome of menopause. The gene discussed is CYP19A1; the disease is menopause.